Healthcare & Life Sciences

Nightstar Therapeutics

United Kingdom
Sign in to unlock

About

Nightstar Therapeutics was a clinical-stage biotechnology company developing gene therapies using AAV vectors to treat inherited retinal disorders and hereditary vision-loss conditions.

Explore Nightstar Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing